162 related articles for article (PubMed ID: 27565356)
41. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
42. N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule.
Wojczyk BS; Takahashi N; Levy MT; Andrews DW; Abrams WR; Wunner WH; Spitalnik SL
Glycobiology; 2005 Jun; 15(6):655-66. PubMed ID: 15677380
[TBL] [Abstract][Full Text] [Related]
43. N-acetylgalactosamine glycans function in cancer cell adhesion to endothelial cells: A role for truncated O-glycans in metastatic mechanisms.
Bapu D; Runions J; Kadhim M; Brooks SA
Cancer Lett; 2016 Jun; 375(2):367-374. PubMed ID: 26994652
[TBL] [Abstract][Full Text] [Related]
44. Functional roles of N-glycans in cell signaling and cell adhesion in cancer.
Zhao YY; Takahashi M; Gu JG; Miyoshi E; Matsumoto A; Kitazume S; Taniguchi N
Cancer Sci; 2008 Jul; 99(7):1304-10. PubMed ID: 18492092
[TBL] [Abstract][Full Text] [Related]
45. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
46. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
47. Antibody recognition of aberrant glycosylation on the surface of cancer cells.
Soliman C; Yuriev E; Ramsland PA
Curr Opin Struct Biol; 2017 Jun; 44():1-8. PubMed ID: 27821276
[TBL] [Abstract][Full Text] [Related]
48. Cell surface protein glycosylation in cancer.
Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
[TBL] [Abstract][Full Text] [Related]
49. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
50. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
Cornelissen LA; Van Vliet SJ
Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
[TBL] [Abstract][Full Text] [Related]
51. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
Kizuka Y; Taniguchi N
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
[TBL] [Abstract][Full Text] [Related]
52. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
53. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
[TBL] [Abstract][Full Text] [Related]
54. Specific N-glycan alterations are coupled in EMT induced by different density cultivation of MCF 10A epithelial cells.
Xu Q; Niu X; Wang W; Yang W; Du Y; Gu J; Song L
Glycoconj J; 2017 Apr; 34(2):219-227. PubMed ID: 28035583
[TBL] [Abstract][Full Text] [Related]
55. Glycan changes: cancer metastasis and anti-cancer vaccines.
Li M; Song L; Qin X
J Biosci; 2010 Dec; 35(4):665-73. PubMed ID: 21289447
[TBL] [Abstract][Full Text] [Related]
56. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
[TBL] [Abstract][Full Text] [Related]
57. Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology.
Chiang AW; Li S; Spahn PN; Richelle A; Kuo CC; Samoudi M; Lewis NE
Curr Opin Struct Biol; 2016 Oct; 40():104-111. PubMed ID: 27639240
[TBL] [Abstract][Full Text] [Related]
58. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
59. A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
Audfray A; Beldjoudi M; Breiman A; Hurbin A; Boos I; Unverzagt C; Bouras M; Lantuejoul S; Coll JL; Varrot A; Le Pendu J; Busser B; Imberty A
PLoS One; 2015; 10(6):e0128190. PubMed ID: 26042789
[TBL] [Abstract][Full Text] [Related]
60. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
